This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a security measure to protect unauthorized release of information? a. ... (Read 96 times)

Deast7027

  • Hero Member
  • *****
  • Posts: 538
Which of the following is a security measure to protect unauthorized release of information?
 
  a. Asking the caller if they are related to the patient in which they are inquiring
  b. Ensuring the computer screen used to access medical information about patients is not able to be seen by others
  c. Talking on your cell phone about a patient while at a restaurant
  d. Accepting an unsigned release-of-information form from someone other than the patient

Question 2

If a patient is told by an insurance company that the diagnosis provided by the physician is not appropriate for the procedure billed, to whom can the patient appeal to have the medical record diagnosis changed?
 
  a. Insurance company
  b. Physician
  c. Governing agency
  d. Social Security



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

smrtceo

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

Answer: b

Answer to Question 2

Answer: b




Deast7027

  • Member
  • Posts: 538
Reply 2 on: Jun 27, 2018
Thanks for the timely response, appreciate it


aliotak

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Gracias!

 

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

For a complete list of videos, visit our video library